About this webinar:
How is pharma determining the right global footprint for their clinical trials?
In this webinar, a panel of clinical operations leaders discuss their process for identifying the best regions to expand clinical trial opportunities and how they match that to an evolving portfolio, and how they respond to shifting geopolitical landscapes.
More specifically, the panelists discuss:
- How to assess if your global footprint needs to change
- The right strategy around infrastructure, including when to outsource
- How to build in readiness and the capabilities to pivot when necessary
This discussion is a rebroadcast from the 2025 DPHARM conference. For more information on this panel and others, visit DPHARMconference.com.
About this webinar’s associated conference:
DPHARM®: Disruptive Innovations to Advance Clinical Research offers an unparalleled opportunity to hear senior clinical operation executives and innovative thought leaders unveil the latest innovations to modernize clinical trials and reduce patient burden. The concept of DPHARM was founded by Pfizer and Janssen, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program.
About Fierce Life Sciences:
Fierce Life Sciences offers a full suite of news, analysis and event education, all in one place. From preclinical research to market and beyond, our team of editors and handpicked experts deliver insights you can source with confidence and events, both virtual and live, that support professional and business growth. Come experience biopharma with us. #BeFierce
Moderators
Speakers
